Response by Singfer and Defreyne to Letter Regarding Article, “Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.